Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.
Westphal
M
M
Department of Neurological Surgery, University Hospital Eppendorf, Hamburg, Germany.
Hamel
W
W
Zirkel
D
D
Herrmann
H D
HD
Bilzer
T
T
Reifenberger
G
G
Schober
R
R
Wechsler
W
W
Albert
F K
FK
Behnke
J
J
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000494:pharmacology / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D002455:Cell Division / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology; D066246:ErbB Receptors / Q000096:biosynthesis* / Q000276:immunology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D005910:Glioma / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000276:immunology; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D013498:Suramin / Q000494:pharmacology; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D009363:Neoplasm Proteins; D013498:Suramin; D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases